Takeda and Millennium - Top 10 deals of 2008

FierceBiotech's top 10 deals of 2008, featuring the Takeda's acquisition of Millenium Pharmaceuticals.Who: Takeda
With: Millennium‎
What: $8.8B buyout

Summary: With an eye on expanding in the U.S. market--and capitalizing on the weak dollar--Japan's Takeda offered $8.8 billion for Millennium Pharmaceuticals in April. Takeda, which is facing patent expirations for Actos and Prevacid, picked up Millennium's cancer drug Velcade in the deal. The company hopes to turn Velcade into a global blockbuster. Millennium had more than a half billion dollars in revenue last year and also has a number of inflammation and cancer therapies in the pipeline, which addresses Takeda's interest in oncology.

Takeda and Millennium - Top 10 deals of 2008

Suggested Articles

NASH leaders weigh in on the need for a drug for the disease and the challenges in getting it to patients.

The $210 million fund began life by leading a $17 million series A round in Quellis Biosciences.

The nine-story building will house Amgen’s Bay Area employees when it opens early in 2022.